Development and validation of a modified SOFA score for mortality prediction in candidemia patients

Abstract Candidemia is a life-threatening bloodstream infection associated with high mortality rates, particularly in critically ill patients. Accurate risk stratification is crucial for timely intervention and could improve patient outcomes. This study aimed to enhance the predictive performance of...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaofei Liu, Ranran Ding, Guangming Yang, Yuling Qiao, Zhen Ma, Yaping Feng, Feng Qu, Qiang Meng
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-04786-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849769187544662016
author Xiaofei Liu
Ranran Ding
Guangming Yang
Yuling Qiao
Zhen Ma
Yaping Feng
Feng Qu
Qiang Meng
author_facet Xiaofei Liu
Ranran Ding
Guangming Yang
Yuling Qiao
Zhen Ma
Yaping Feng
Feng Qu
Qiang Meng
author_sort Xiaofei Liu
collection DOAJ
description Abstract Candidemia is a life-threatening bloodstream infection associated with high mortality rates, particularly in critically ill patients. Accurate risk stratification is crucial for timely intervention and could improve patient outcomes. This study aimed to enhance the predictive performance of the sequential organ failure assessment (SOFA) score by developing a modified SOFA (mSOFA) score, which is specifically designed for candidemia patients. Using data from MIMIC-III, MIMIC-IV, and ICU-JN databases, we identified key prognostic variables through LASSO regression and integrated into the mSOFA_3 model. The model incorporated respiratory_SOFA, coagulation_SOFA, and circulatory_SOFA along with clinical biomarkers, including lactate, albumin, and blood urea nitrogen. The mSOFA_3 model demonstrated superior predictive performance across multiple machine learning algorithms, with the logistic regression-based model achieving the highest AUC of 0.826 in the internal validation cohort and 0.813 in the test cohort. Kaplan-Meier survival analysis further validated the model’s utility in stratifying patients into high-risk and low-risk groups with distinct survival outcomes. These findings highlight the mSOFA_3 as a robust and clinically relevant tool for early risk stratification, offering potential for improved decision-making and therapeutic management in critically ill patients with candidemia.
format Article
id doaj-art-98bcd4acb17f4eeb87ef3d686bbb8588
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-98bcd4acb17f4eeb87ef3d686bbb85882025-08-20T03:03:32ZengNature PortfolioScientific Reports2045-23222025-07-0115111110.1038/s41598-025-04786-8Development and validation of a modified SOFA score for mortality prediction in candidemia patientsXiaofei Liu0Ranran Ding1Guangming Yang2Yuling Qiao3Zhen Ma4Yaping Feng5Feng Qu6Qiang Meng7Department of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalDepartment of Intensive Care Unit, Jining NO. 1 People’s HospitalAbstract Candidemia is a life-threatening bloodstream infection associated with high mortality rates, particularly in critically ill patients. Accurate risk stratification is crucial for timely intervention and could improve patient outcomes. This study aimed to enhance the predictive performance of the sequential organ failure assessment (SOFA) score by developing a modified SOFA (mSOFA) score, which is specifically designed for candidemia patients. Using data from MIMIC-III, MIMIC-IV, and ICU-JN databases, we identified key prognostic variables through LASSO regression and integrated into the mSOFA_3 model. The model incorporated respiratory_SOFA, coagulation_SOFA, and circulatory_SOFA along with clinical biomarkers, including lactate, albumin, and blood urea nitrogen. The mSOFA_3 model demonstrated superior predictive performance across multiple machine learning algorithms, with the logistic regression-based model achieving the highest AUC of 0.826 in the internal validation cohort and 0.813 in the test cohort. Kaplan-Meier survival analysis further validated the model’s utility in stratifying patients into high-risk and low-risk groups with distinct survival outcomes. These findings highlight the mSOFA_3 as a robust and clinically relevant tool for early risk stratification, offering potential for improved decision-making and therapeutic management in critically ill patients with candidemia.https://doi.org/10.1038/s41598-025-04786-8CandidemiaSequential organ failure assessmentLactateBUNAlbumin
spellingShingle Xiaofei Liu
Ranran Ding
Guangming Yang
Yuling Qiao
Zhen Ma
Yaping Feng
Feng Qu
Qiang Meng
Development and validation of a modified SOFA score for mortality prediction in candidemia patients
Scientific Reports
Candidemia
Sequential organ failure assessment
Lactate
BUN
Albumin
title Development and validation of a modified SOFA score for mortality prediction in candidemia patients
title_full Development and validation of a modified SOFA score for mortality prediction in candidemia patients
title_fullStr Development and validation of a modified SOFA score for mortality prediction in candidemia patients
title_full_unstemmed Development and validation of a modified SOFA score for mortality prediction in candidemia patients
title_short Development and validation of a modified SOFA score for mortality prediction in candidemia patients
title_sort development and validation of a modified sofa score for mortality prediction in candidemia patients
topic Candidemia
Sequential organ failure assessment
Lactate
BUN
Albumin
url https://doi.org/10.1038/s41598-025-04786-8
work_keys_str_mv AT xiaofeiliu developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT ranranding developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT guangmingyang developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT yulingqiao developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT zhenma developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT yapingfeng developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT fengqu developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients
AT qiangmeng developmentandvalidationofamodifiedsofascoreformortalitypredictionincandidemiapatients